Phenoxybenzamine in prostatic obstruction.
A short controlled trial has confirmed that phenoxybenzamine (10 or 20 mg/day) relaxes the resting proximal urethra and reduces the voiding frequency in patients with benign prostatic hypertrophy.
D000368:Aged; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010643:Phenoxybenzamine / Q000009:adverse effects / Q000627:therapeutic use*; D011312:Pressure; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011897:Random Allocation
D010643:Phenoxybenzamine